Transgenic Models of Inherited Neuropathy

Peripheral Neuropathy

Volumn 2, Issue , 2005, Pages 1561-1583

  Robertson, Andrea ^a   Huxley, Clare ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745267332     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50068-5     Document Type: Chapter

References (135)

1. Abel A., Bone L.J., Messing A., et al. Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J. Neuropathol. Exp. Neurol. 1999, 58:702.
2. Abrams C., Yi Ri S., Bargiello A. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Brain Res. Rev. 2000, 32:203.
3. Adlkofer K., Martini R., Aguzzi A., et al. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 1995, 11:274.
4. Adlkofer K., Naef R., Suter U. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J. Neurosci. Res. 1997, 49:671.
5. Aguayo A.J., Attiwell M., Trecarten J., et al. Abnormal myelination in transplanted Trembler mouse Schwann cells. Nature 1977, 265:73.
6. Altevogt B.M., Kleopa K.A., Postma F.R., et al. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J. Neurosci. 2002, 22:6458.
7. Anzini P., Neuberg D., Schachner M., et al. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 1997, 17:4545.
8. Ayers M.M., Anderson R.M. Onion bulb neuropathy in the Trembler mouse: a model of hypertrophic interstitial neuropathy (Dejerine-Sottas) in man. Acta Neuropathol. (Berl.) 1973, 25:54.
9. Ayers M.M., Anderson R.M. Development of onion bulb neuropathy in the Trembler mouse: comparison with normal nerve maturation. Acta Neuropathol. (Berl.) 1975, 32:43.
10. Baechner D., Liehr T., Hameister H., et al. Widespread expression of the peripheral myelin protein-22 gene (pmp22) in neural and non-neural tissues during murine development. J. Neurosci. Res. 1995, 42:733.
11. Balice-Gordon R., Bone L., Scherer S. Functional gap junctions in the Schwann cell myelin sheath. J. Cell Biol. 1998, 142:1095.
12. Bascles L., Bonnet J., Garbay B. Expression of the PMP-22 gene in Trembler mutant mice: comparison with the other myelin protein genes. Dev. Neurosci. 1992, 14:336.
13. Bergoffen J., Scherer S.S., Wang S., et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993, 262:2039.
14. Boerkoel C.F., Takashima H., Stankiewicz P., et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am. J. Hum. Genet. 2001, 68:325.
15. Bucciantini M., Giannoni E., Chiti F., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416:507.
16. Chandross K.J., Kessler J.A., Cohen R.I., et al. Altered connexin expression after peripheral nerve injury. Mol. Cell. Neurosci. 1996, 1996:501.
17. Colby J., Nicholson R., Dickson K.M., et al. PMP22 carrying the trembler of trembler-J mutations is intracellularly retained in myelinating Schwann cells. Neurobiol. Dis. 2000, 7:561.
18. D'Urso D., Prior R., Greiner-Petter R., et al. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci. 1998, 18:731.
19. Dytrych L., Sherman D.L., Gillespie C.S., et al. Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J. Biol. Chem. 1998, 273:5794.
20. Eng L.F., Yu A.C.H., Lee Y.L. Astrocytic response to injury. Prog. Brain Res. 1992, 4:353.
21. Falconer D.S. Two new mutants, 'Trembler' and 'Reeler,' with neurological actions in the house mouse (Mus musculus L.). J. Genet. 1951, 50:192.
22. Fanning A.S., Anderson J.M. Protein molecules as organizers of membrane structure. Curr. Opin. Cell Biol. 1999, 11:432.
23. Filbin M.T., Walsh F.S., Trapp B.D., et al. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 1990, 344:871.
24. Frei R., Mötzing S., Kinkelin I., et al. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J. Neurosci. 1999, 19:6058.
25. Gabreëls-Festen A.A., Hoogendijk J.E., Meijerink P., et al. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 1996, 47:761.
26. Gale A.N., Gomez S., Duchen L.W. Changes produced by a hypomyelinating neuropathy in muscle and its innervation. Brain 1982, 105:373.
27. Garbay B., Bonnet J. P0 protein in normal, trembler heterozygous/homozygous mice during active PNS myelination. Neuroreport 1992, 3:594.
28. Garcia-Mata R., Bebik Z., Sorscher E.J., et al. Characterization and dynamics of aggresome formation by a cytosolic GFP chimera. J. Cell. Biol. 1999, 146:1239.
29. Garcia-Mata R., Gao Y.-A., Sztul E. Hassles with taking out the garbage: aggravating aggresomes. Traffic 2002, 3:388.
30. Giese K.P., Martini R., Lemke G., et al. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992, 71:565.
31. Gillespie C.S., Sherman D.L., Fleetwood-Walker S.M., et al. Peripheral demyelination and neuropathic pain behaviour in periaxin deficient mice. Neuron 2000, 26:523.
32. Gong X., Li E., Klier G., et al. Disruption of the a3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 1997, 91:833.
33. Greenfield S.S., Brostoff E.H., Eylar E.H., et al. Protein composition of myelin of the peripheral nervous system. J. Neurochem. 1973, 20:1207.
34. Guilbot A., Williams A., Ravisé N., et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum. Mol. Genet. 2001, 10:415.
35. Harris B.Z., Lim W.A. Mechanism and role of PDZ domains in signaling complex assembly. J. Cell Sci. 2001, 114:3219.
36. Henry E.W., Cowen J.S., Sidman R.L. Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination. Exp. Neurol. 1983, 42:688.
37. Henry E.W., Sidman R.L. Long lives for homozygous Trembler mutant mice despite virtual absence of peripheral nerve myelin. Science 1988, 241:344.
38. Hoogendijk J.E., Janssen E.A.M., Gabreëls-Festen A.A.W.M., et al. Allelic heterogeneity in hereditary motor and sensory neuropathy type Ia (Charcot-Marie-Tooth disease type Ia). Neurology 1993, 3:1010.
39. Huxley C., Passage E., Manson A., et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 1996, 5:563.
40. Huxley C., Passage E., Robertson A.M., et al. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum. Mol. Genet. 1998, 7:449.
41. Ikegami T., Ikeda H., Aoyama M., et al. Novel mutations of the peripheral myelin protein 22 gene in two pedigrees with Dejerine-Sottas disease. Hum. Genet. 1998, 102:294.
42. InuzGBRa T., Quarles R.H., Heath J., et al. A human lymphocyte antigen is shared with a group of glycoproteins in peripheral nerve. Neurosci. Lett. 1985, 51:105.
43. Ionasescu V.V., Searby C.C., Ionasescu R., et al. Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 1997, 20:97.
44. Isaacs A.M., Davies K.E., Hunter A.J., et al. Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum. Mol. Genet. 2000, 9:1865.
45. Isaacs A.M., Jeans A., Oliver P., et al. Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated neuropathy. Mol. Cell. Neurosci. 2002, 21:114.
46. Jacobs J.M., Cavanaugh J.B. Aggregations of filaments in Schwann cells of spinal roots of the normal rat. J. Neurocytol. 1972, 1:161.
47. Johnston J.A., Dalton M.J., Gurney M.E., et al. Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12571.
48. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 1998, 143:1883.
49. King, R. H. M., Muddle, J. R., Nourallah, M., et al.: An investigation into axonal loss in transgenic and spontaneous mutant mouse models of HMSN1a. Manuscript in preparation, 2003.
50. Kirschner D.A., Szumowski K., Gabreëls-Festen A.A., et al. Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects. J. Neurosci. Res. 1996, 46:502.
51. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 10:524.
52. Lemke G., Lamar E., Patterson J. Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron 1988, 1:73.
53. Levi G., Topilko P., Schneider-Maunoury S., et al. Defective bone formation in Krox-20 mutant mice. Development 1996, 122:113.
54. Liehr T., Rautenstrauss B. The peripheral myelin protein 22kDa (PMP22) gene is expressed in non-neural epithelial tissues of mouse, rat, cattle and human [abstract]. Am. J. Hum. Genet. 1997, 61(SS):1015.
55. Low P.A. Hereditary hypertrophic neuropathy in the Trembler mouse. Part 1. Histopathological studies: light microscopy. J. Neurol. Sci. 1976, 30:327.
56. Low P.A. Hereditary hypertrophic neuropathy in the Trembler mouse. Part 2. Histopathological studies: electron microscopy. J. Neurol. Sci. 1976, 30:343.
57. Low P.A. The evolution of 'onion bulbs' in the hereditary hypertrophic neuropathy of the Trembler mouse. Neuropathol. Appl. Neurobiol. 1977, 3:81.
58. Low P.A., McLeod J.G. Hereditary demyelinating neuropathy in the Trembler mouse. J. Neurol. Sci. 1975, 26:565.
59. Lupski J.R., de Oca-Luna R., Slaugenhaupt S., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991, 66:219.
60. Magyar J.P., Martini R., Ruelicke T., et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 1996, 16:5351.
61. Manfioletti G., Ruaro M.E., Del Sal G., et al. A growth arrest-specific (gas) gene codes for a membrane protein. Mol. Cell. Biol. 1990, 10:2924.
62. Martini R., Zielasek J., Toyka K.V., et al. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 1995, 11:281.
63. Maycox P.R., Ortuno D., Burrola P., et al. A transgenic mouse model of human hereditary neuropathy with liability to pressure palsies. Mol. Cell. Neurosci. 1997, 8:405.
64. Melcangi R.C., Azcoitia I., Ballabio M., et al. Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves. Prog. Neurobiol. 2003, 71:57.
65. Menichella D., Xu W., Jiang H., et al. The absence of myelin P0 protein produces a novel molecular phenotype in Schwann cells. Ann. N. Y. Acad. Sci. 1999, 883:281.
66. Müller H.W. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses. Glia 2000, 29:182.
67. Murphy P., Topilko P., Schneider-Maunoury S., et al. The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 1996, 122:2847.
68. Naef R., Adlkofer K., Lescher B., et al. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol. Cell. Neurosci. 1997, 9:13.
69. Naef R., Suter U. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol. Dis. 1999, 6:1.
70. Nagakawa M., Suehara M., Saito A., et al. A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths. Neurology 1999, 52:1271.
71. Nagarajan R., Svaren J., Le N., et al. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001, 30:355.
72. Nelles E., Bützler C., Jung D., et al. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9565.
73. Nicholson S., Gómes D., Néchaud B., et al. Altered gene expression in Schwann cells of connexin32 knockout animals. J. Neurosci. Res. 2001, 66:23.
74. Niemann S., Sereda M., Suter U., et al. Uncoupling of myelin assembly and Schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J. Neurosci. 2000, 20:4120.
75. Norrell J.C., Jamon M., Riviere G., et al. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur. J. Neurosci. 2001, 13:1625.
76. Notterpek L., Roux K.J., Amici S.A., et al. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14404.
77. Notterpek L., Ryan M.C., Tobler A.R., et al. PMP22 accumulation in aggresomes: implications for CMT1 pathology. Neurobiol. Dis. 1999, 6:450.
78. Notterpek L., Shooter E.M., Snipes G.J. Upregulation of the endosomal-lysosomal pathway in the Trembler-J neuropathy. J. Neurosci. 1997, 17:4190.
79. O'Donovan K.J., Tourtellotte W.G., Milbrandt J., et al. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuro-science. Trends Neurosci. 1999, 22:167.
80. Ohnishi A., Yamamoto T., Yamamoto S., et al. Myelinated fibres in Charcot-Marie-Tooth disease type 1B with Arg98His mutation of P0 protein. J. Neurol. Sci. 1999, 171:97.
81. Owens G.C., Boyd C.J. Expressing antisense P0 RNA in Schwann cells perturbs myelination. Development 1991, 112:639.
82. Patel P.I., Roa B.B., Welcher A.A., et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1992, 1:159.
83. Paul D.L. New functions for gap junctions. Curr. Opin. Cell Biol. 1995, 7:665.
84. Perea J., Robertson A., Tolmachova T., et al. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum. Mol. Genet. 2001, 10:1007.
85. Perkins C.S. Schwann cell multiplication in Trembler mice. Neuropathol. Appl. Neurobiol. 1981, 7:115.
86. Perkins C.S., Aguayo A.J., Bray G.M. Behaviour of Schwann cells from the Trembler mouse unmyelinated fibres transplanted into myelinated nerves. Exp. Neurol. 1981, 71:515.
87. Planté-Bordeneuve V., Guiochon-Mantel A., Lacroix C., et al. The Roussy-Lévy family: from the original description to the gene. Ann. Neurol. 1999, 46.
88. Previtali S., Quattrini A., Fasolini M., et al. Epitope-tagged P0 glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. J. Cell Biol. 2000, 151:1035.
89. Raeymaekers P., Timmerman V., Nelis E., et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul. Disord. 1991, 1:93.
90. Ressot C., Bruzzone R. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Brain Res. Rev. 2000, 32:192.
91. Roa B.B., Dyck P.J., Marks H.G., et al. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat. Genet. 1993, 5:269.
92. Robertson A., Perea J., Tolmachova T., et al. Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice. Gene 2002, 282:65.
93. Robertson A.M., Huxley C., King R.H.M., et al. Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice. J. Anat. 1999, 195:331.
94. Robertson A.M., King R.H.M., Muddle J.R., et al. Abnormal Schwann cell/axon interactions in the Trembler-J mouse. J. Anat. 1997, 190:423.
95. Robertson A.M., Perea J., McGuigan A., et al. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J. Anat. 2002, 200:377.
96. Ryan M.C., Notterpek L., Tobler A.R., et al. Role of peripheral myelin protein 22 N-linked glycan in oligomer stability. J. Neurochem. 2000, 75:1465.
97. Ryan M.C., Shooter E.M., Notterpek L. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol. Dis. 2002, 10:109.
98. Sahenk Z., Chen L. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts. J. Neurosci. Res. 1988, 51:174.
99. Sancho S., Magyar J.P., Aguzzi A., et al. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 1999, 122:1563.
100. Sanders C.R., Ismail-Beigi F., McEnery M.W. Mutations of the peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 2001, 40:9453.
101. Scherer S., Bone L.J., Deschenes S.M., et al. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. Gap Junction-Mediated Intercellular Signalling in Health and Disease (Novartis Foundation Symposium 219) 1999, John Wiley and Sons, New York. G. Cardew (Ed.).
102. Scherer S., Xu Y., Bannerman P., et al. Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. Development 1995, 121:4265.
103. Scherer S., Xu Y., Nelles E., et al. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 1998, 24:8.
104. Scherer S.S., Deschenes S.M., Xu Y.-T., et al. Connexin32 is a myelin-related protein in the PNS and CNS. J. Neurosci. 1995, 15:8281.
105. Schneider-Maunoury S., Topilko P., Seitanidou T., et al. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell 1993, 75:1199.
106. Sereda M., Griffiths I., Pühlhofer A., et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996, 16:1049.
107. Sereda M., Hörste G., Suter U., et al. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat. Med. 2003, 9:1533.
108. Shapiro L., Doyle J.P., Henesley P., et al. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996, 17:435.
109. Sidman R.L., Cowen J.S., Eicher E.M. Inherited muscle and nerve diseases in mice: a tabulation with commentary. Ann. N. Y. Acad. Sci. 1979, 317:497.
110. Sindou P., Vallat J.-M., Chapon F., et al. Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease. Muscle Nerve 1999, 22:99.
111. Snipes G.J., Suter U., Welcher A.A., et al. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J. Cell Biol. 1992, 117:225.
112. Spreyer P., Kuhn G., Hanemann C.O., et al. Axon-regulated expression of a Schwann cell transcript that is homologous to a "growth arrest-specific" gene. EMBO J. 1991, 10:3661.
113. Suh J.-G., Ichihara N., Saigoh K., et al. An in-frame deletion in peripheral myelin protein-22 gene causes hypomyelination and cell death in Schwann cells in the new TREMBLER mutant mice. Neuroscience 1997, 79:735.
114. Suter U., Welcher A.A., Ozcelik T., et al. Trembler mouse carries a point mutation in a myelin gene. Nature 1992, 356:241.
115. Takashima H., Boerkoel C.F., De Jonge P., et al. Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann. Neurol. 2002, 51:709.
116. Thomas F.P., Lebo R.V., Rosoklija G., et al. Tomaculous neuropathy in chromosome 1 Charcot-Marie-Tooth syndrome. Acta Neuropathol. (Berl.) 1994, 87:91.
117. Timmerman V., De Jonghe P., Ceuterick C., et al. Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology 1999, 52:1827.
118. Tobler A.R., Liu N., Mueller L., et al. Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:483.
119. Tobler A.R., Notterpek L., Naef R., et al. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wildtype protein by direct interaction. J. Neurosci. 1999, 19:2027.
120. Topilko P., Schneider-Maunoury S., Levi G., et al. Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796.
121. Toyka K., Zielasek J., Ricker K., et al. Hereditary neuromyotonia: a mouse model associated with deficiency or increased gene dosage of the PMP22 gene. J. Neurol. Neurosurg. Psychiatry 1997, 63:812.
122. Tran P.B., Miller R.J. Aggregates in neurodegenerative disease: crowds and power?. Trends Neurosci. 1999, 22:194.
123. Turman J.E., ChopiGBR N.B., Shuler C.F. The Krox-20 mutation differentially affects the development of masticatory muscles. Dev. Neurosci. 2001, 23:113.
124. Tyson J., Ellis D., Fairbrother U., et al. Hereditary demyelinating neuropathies of infancy: a genetically complex syndrome. Brain 1997, 120:47.
125. Valentijn L.J., Baas F., Wolterman R.A., et al. Identical point mutations of PMP-22 in trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1992, 2:288.
126. Valentijn L.J., Ouvrier R.A., Bosch N.H., et al. Dejerine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum. Mutat. 1995, 5:76.
127. Vallat J.M., Sindou P., Garbay B., et al. Expression of myelin proteins in the adult heterozygous Trembler mouse. Acta Neuropathol. (Berl.) 1999, 98:281.
128. Verhagen W.I.M., Gabreëls-Festen A.A.W.M., Van Wensen P.J.M., et al. Hereditary neuropathy with liability to pressure palsies: a clinical, electrophysiological and morphological study. J. Neurol. Sci. 1993, 116:176.
129. Warner L.E., Mancias P., Butler I.J., et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 1998, 18:382.
130. Warner L.E., Svaren J., Milbrandt J., et al. Functional consequences of mutations in the early growth response 2 gene (EG2) correlate with the severity of human myelinopathies. Hum. Mol. Genet. 1999, 8:1245.
131. Welcher A.A., Suter U., De Leon M., et al. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7195.
132. White T.W., Goodenough D.A., Paul D.L. Targeted ablation of connexin50 in mice results in microphthalmia and zonular pulverulent cataracts. J. Cell Biol. 1998, 143:815.
133. Wrabetz L., Feltri M.L., Quattrini A., et al. P0 overexpression causes congenital hypomyelination of peripheral nerves. J. Cell Biol. 2000, 148:1021.
134. Xu W., Manichella D., Jiang H., et al. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J. Neurosci. Res. 2000, 60:714.
135. Zimmerman M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 2001, 29:23.